相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma
Paul G. Richardson et al.
BLOOD (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Gene-Dosage Dependent Overexpression at the 13q Amplicon Identifies DIS3 as Candidate Oncogene in Colorectal Cancer Progression
Florence L. M. de Groen et al.
GENES CHROMOSOMES & CANCER (2014)
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies
Simona Caltagirone et al.
HAEMATOLOGICA (2014)
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
B. A. Walker et al.
LEUKEMIA (2014)
Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma
L. Melchor et al.
LEUKEMIA (2014)
Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective-A report by Polish Myeloma Study Group
Adam Walter-Croneck et al.
LEUKEMIA RESEARCH (2014)
Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism and suggest hDIS3 PIN domain as a potential drug target
Rafal Tomecki et al.
NUCLEIC ACIDS RESEARCH (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
P. Leif Bergsagel et al.
BLOOD (2013)
COSMIC (Cohort Studies of Memory in an International Consortium): An international consortium to identify risk and protective factors and biomarkers of cognitive ageing and dementia in diverse ethnic and sociocultural groups
Perminder S. Sachdev et al.
BMC NEUROLOGY (2013)
Genetic Amplification of the NOTCH Modulator LNX2 Upregulates the WNT/β-Catenin Pathway in Colorectal Cancer
Jordi Camps et al.
CANCER RESEARCH (2013)
Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials
Pieter Sonneveld et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Minor clone provides a reservoir for relapse in multiple myeloma
F. Magrangeas et al.
LEUKEMIA (2013)
Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product
Filipa P. Reis et al.
PLOS ONE (2013)
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
E. Leich et al.
BLOOD CANCER JOURNAL (2013)
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
Kai Neben et al.
BLOOD (2012)
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma
Brian A. Walker et al.
BLOOD (2012)
Darwinian evolution and tiding clones in multiple myeloma
Nizar J. Bahlis
BLOOD (2012)
Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides
Jan B. Egan et al.
BLOOD (2012)
Clonal competition with alternating dominance in multiple myeloma
Jonathan J. Keats et al.
BLOOD (2012)
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders
Fiona M. Ross et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Performance comparison of benchtop high-throughput sequencing platforms
Nicholas J. Loman et al.
NATURE BIOTECHNOLOGY (2012)
Evolution of the cancer genome
Lucy R. Yates et al.
NATURE REVIEWS GENETICS (2012)
The CR3 motif of Rrp44p is important for interaction with the core exosome and exosome function
Daneen Schaeffer et al.
NUCLEIC ACIDS RESEARCH (2012)
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C. Munshi et al.
BLOOD (2011)
The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates
Uttiya Basu et al.
CELL (2011)
Genomics in Multiple Myeloma
Nikhil C. Munshi et al.
CLINICAL CANCER RESEARCH (2011)
Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains
Hong Chang et al.
LEUKEMIA RESEARCH (2011)
Initial genome sequencing and analysis of multiple myeloma
Michael A. Chapman et al.
NATURE (2011)
Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
Thorsten Stuehmer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The human core exosome interacts with differentially localized processive RNases: hDIS3 and hDIS3L
Rafal Tomecki et al.
EMBO JOURNAL (2010)
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
Hitoshi Nagaoka et al.
INTERNATIONAL IMMUNOLOGY (2010)
Bortezomib Plus Dexamethasone Induction Improves Outcome of Patients With t(4;14) Myeloma but Not Outcome of Patients With del(17p)
Herve Avet-Loiseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance
Lei Shi et al.
ONCOTARGET (2010)
DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma
Martin Kropff et al.
ANNALS OF HEMATOLOGY (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
The exosome contains domains with specific endoribonuclease, exoribonuclease and cytoplasmic mRNA decay activities
Daneen Schaeffer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
The N-terminal PIN domain of the exosome subunit Rrp44 harbors endonuclease activity and tethers Rrp44 to the yeast core exosome
Claudia Schneider et al.
NUCLEIC ACIDS RESEARCH (2009)
Structural organization of the RNA-degrading exosome
Esben Lorentzen et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2008)
Structure of the active subunit of the yeast exosome core, Rrp44: Diverse modes of substrate recruitment in the RNase II nuclease family
Esben Lorentzen et al.
MOLECULAR CELL (2008)
The exosome subunit Rrp44 plays a direct role in RNA substrate recognition
Claudia Schneider et al.
MOLECULAR CELL (2007)
The exosome and RNA quality control in the nucleus
Stepanka Vanacova et al.
EMBO REPORTS (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion
V. Sagaster et al.
LEUKEMIA (2007)
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials
S. Jagannath et al.
LEUKEMIA (2007)
Unravelling the dynamics of RNA degradation by ribonuclease II and its RNA-bound complex
Carlos Frazao et al.
NATURE (2006)
Cytogenetics and molecular cytogenetics in multiple myeloma
Peter Liebisch et al.
EUROPEAN JOURNAL OF CANCER (2006)
分享论文
